{"transactions":[{"id":854621,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62130,"kind":"person","name":"Draghia-Akli Ruxandra","position":1,"cik":"0002041719","reported_name":"Draghia-Akli Ruxandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Non-Statutory Stock Option NQ","published_at":"2026-03-09T22:11:00.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":139500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This Form 4/A has been filed solely to amend the exercise price as originally reported in Column 2 and price of derivative security as originally reported in Column 8 of Table II of the Reporting Person's Form 4 filed on March 5, 2026. All other information remains unchanged from the March 5, 2026 filing."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4/A has been filed solely to amend the exercise price as originally reported in Column 2 and price of derivative security as originally reported in Column 8 of Table II of the Reporting Person's Form 4 filed on March 5, 2026. All other information remains unchanged from the March 5, 2026 filing."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One quarter (1/4) of the shares subject to this option granted under the Plan vest on the first anniversary of March 2, 2026, and the remaining three-quarters (3/4) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date."}],"balance_after":139500,"derivative":{"exercise_price":10.11,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":139500},"source":{"system":"sec-edgar","filing":"0001104659-26-025366","document":"tm268290-4_4aseq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926025366/tm268290-4_4aseq1.xml","form_type":"4/A","original_submission_date":"2026-03-05"}},{"id":859548,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62130,"kind":"person","name":"Draghia-Akli Ruxandra","position":1,"cik":"0002041719","reported_name":"Draghia-Akli Ruxandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T11:00:47.000Z","date":"2026-03-03","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":26667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of March 3, 2025, in each case subject to continued employment through such vesting date."}],"balance_after":53333,"derivative":{"exercise_price":0,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":26667},"source":{"system":"sec-edgar","filing":"0001104659-26-023709","document":"tm268076-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023709/tm268076-5_4seq1.xml","form_type":"4"}},{"id":859547,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62130,"kind":"person","name":"Draghia-Akli Ruxandra","position":1,"cik":"0002041719","reported_name":"Draghia-Akli Ruxandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Non-Statutory Stock Opotion NQ","published_at":"2026-03-05T11:00:47.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":139500,"price":9.09,"value":1268055.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One quarter of the shares subject to this option granted under the Plan vest on the first anniversary of March 2, 2026, and the remaining three-quarters (3/4) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date."}],"balance_after":139500,"derivative":{"exercise_price":9.09,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":139500},"source":{"system":"sec-edgar","filing":"0001104659-26-023709","document":"tm268076-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023709/tm268076-5_4seq1.xml","form_type":"4"}},{"id":859546,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62130,"kind":"person","name":"Draghia-Akli Ruxandra","position":1,"cik":"0002041719","reported_name":"Draghia-Akli Ruxandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Restricted Stock Units","published_at":"2026-03-05T11:00:47.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":93000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, (the \"Plan\") vest on each of the first three (3) anniversaries of March 2, 2026, in each case subject to continued employment through such vesting date."}],"balance_after":101000,"derivative":{"exercise_price":0,"expiration_date":"2036-03-02","underlying":"Common Stock","underlying_shares":93000},"source":{"system":"sec-edgar","filing":"0001104659-26-023709","document":"tm268076-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023709/tm268076-5_4seq1.xml","form_type":"4"}},{"id":859545,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62130,"kind":"person","name":"Draghia-Akli Ruxandra","position":1,"cik":"0002041719","reported_name":"Draghia-Akli Ruxandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2026-03-05T11:00:47.000Z","date":"2026-03-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":11313,"price":9.49,"value":107360.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting."}],"balance_after":23563,"source":{"system":"sec-edgar","filing":"0001104659-26-023709","document":"tm268076-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023709/tm268076-5_4seq1.xml","form_type":"4"}},{"id":859544,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62130,"kind":"person","name":"Draghia-Akli Ruxandra","position":1,"cik":"0002041719","reported_name":"Draghia-Akli Ruxandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Research & Development"}}],"security":"Common Stock","published_at":"2026-03-05T11:00:47.000Z","date":"2026-03-03","kind":"exercise","planned":false,"acquired":true,"shares":26667,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":34876,"source":{"system":"sec-edgar","filing":"0001104659-26-023709","document":"tm268076-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465926023709/tm268076-5_4seq1.xml","form_type":"4"}},{"id":1000890,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62130,"kind":"person","name":"Draghia-Akli Ruxandra","position":1,"cik":"0002041719","reported_name":"Draghia-Akli Ruxandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Section 16"}}],"security":"Restricted Stock Units","published_at":"2025-11-13T22:23:25.000Z","date":"2025-11-11","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":14257,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date."}],"balance_after":28513,"derivative":{"expiration_date":"2034-11-11","underlying":"Common Stock","underlying_shares":14257},"source":{"system":"sec-edgar","filing":"0001104659-25-111494","document":"tm2531249-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465925111494/tm2531249-1_4seq1.xml","form_type":"4"}},{"id":1000889,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62130,"kind":"person","name":"Draghia-Akli Ruxandra","position":1,"cik":"0002041719","reported_name":"Draghia-Akli Ruxandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Section 16"}}],"security":"Common Stock","published_at":"2025-11-13T22:23:25.000Z","date":"2025-11-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":6048,"price":7.4,"value":44755.2,"ownership":{"direct":true},"balance_after":8209,"source":{"system":"sec-edgar","filing":"0001104659-25-111494","document":"tm2531249-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465925111494/tm2531249-1_4seq1.xml","form_type":"4"}},{"id":1000888,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62130,"kind":"person","name":"Draghia-Akli Ruxandra","position":1,"cik":"0002041719","reported_name":"Draghia-Akli Ruxandra","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Section 16"}}],"security":"Common Stock","published_at":"2025-11-13T22:23:25.000Z","date":"2025-11-11","kind":"exercise","planned":false,"acquired":true,"shares":14257,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14257,"source":{"system":"sec-edgar","filing":"0001104659-25-111494","document":"tm2531249-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000110465925111494/tm2531249-1_4seq1.xml","form_type":"4"}},{"id":1224136,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62130,"kind":"person","name":"Draghia-Akli Ruxandra","position":1,"cik":"0002041719","reported_name":"Draghia-Akli Ruxandra","relationship":{"officer":true,"officer_title":"Section 16"}}],"security":"2025 Restricted Stock Units RSU","published_at":"2025-03-05T22:04:25.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date."}],"balance_after":80000,"derivative":{"exercise_price":0,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001593968-25-000305","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000305/primary_01.xml","form_type":"4"}},{"id":1224135,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62130,"kind":"person","name":"Draghia-Akli Ruxandra","position":1,"cik":"0002041719","reported_name":"Draghia-Akli Ruxandra","relationship":{"officer":true,"officer_title":"Section 16"}}],"security":"2025 Non-statutory Stock Option NQ","published_at":"2025-03-05T22:04:25.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":120000,"price":7.87,"value":944400.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date."}],"balance_after":120000,"derivative":{"exercise_price":7.87,"expiration_date":"2035-03-03","underlying":"Common Stock","underlying_shares":120000},"source":{"system":"sec-edgar","filing":"0001593968-25-000305","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396825000305/primary_01.xml","form_type":"4"}},{"id":1367274,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62130,"kind":"person","name":"Draghia-Akli Ruxandra","position":1,"cik":"0002041719","reported_name":"Draghia-Akli Ruxandra","relationship":{"officer":true,"officer_title":"Section 16"}}],"security":"Restricted Stock Units","published_at":"2024-11-13T21:08:57.000Z","date":"2024-11-11","kind":"grant","planned":false,"acquired":true,"shares":42770,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Company common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third (1/3) of the RSUs subject to this grant under the Plan vest on each of the first three (3) anniversaries of the grant date, in each case subject to continued employment through such vesting date."}],"balance_after":42770,"derivative":{"expiration_date":"2034-11-11","underlying":"Common Stock","underlying_shares":42770},"source":{"system":"sec-edgar","filing":"0001593968-24-001367","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824001367/primary_01.xml","form_type":"4"}},{"id":1367273,"issuer":{"id":4632,"kind":"organization","name":"NOVAVAX INC"},"owners":[{"id":62130,"kind":"person","name":"Draghia-Akli Ruxandra","position":1,"cik":"0002041719","reported_name":"Draghia-Akli Ruxandra","relationship":{"officer":true,"officer_title":"Section 16"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-11-13T21:08:57.000Z","date":"2024-11-11","kind":"grant","planned":false,"acquired":true,"shares":64150,"price":9.01,"value":577991.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent (25%) of the shares subject to this option granted under the Novavax, Inc. Amended and Restated 2015 Stock Incentive Plan, as amended, vest on the first anniversary of the grant date, and the remaining seventy-five percent (75%) of the shares vest in equal monthly installments over the following three (3) years, in each case subject to continued employment with the Company through such vesting date."}],"balance_after":64150,"derivative":{"exercise_price":9.01,"exercise_date":"2025-11-11","expiration_date":"2034-11-11","underlying":"Common Stock","underlying_shares":64150},"source":{"system":"sec-edgar","filing":"0001593968-24-001367","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1000694/000159396824001367/primary_01.xml","form_type":"4"}}]}